# A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

> **NCT01820728** · PHASE3 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 93 (actual)

## Conditions studied

- Infertility
- Anovulation

## Interventions

- **DRUG:** DA-3801 Injection
- **DRUG:** Gonal-F®

## Key facts

- **NCT ID:** NCT01820728
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01820728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01820728, "A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01820728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*